Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.74
+0.25 (0.91%)
Feb 18, 2026, 1:20 PM EST - Market open
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.74 billion as of February 18, 2026. Its market cap has increased by 32.70% in one year.
Market Cap
2.74B
Enterprise Value
1.82B
1-Year Change
32.70%
Ranking
Category
Stock Price
$27.74
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.74B, an increase of 734.75%. That is a compound annual growth rate of 42.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 2.71B | -0.83% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.01B |
| Liquidia | 2.94B |
| Spyre Therapeutics | 2.79B |
| Apellis Pharmaceuticals | 2.73B |
| Viridian Therapeutics | 2.70B |
| IDEAYA Biosciences | 2.70B |
| Tarsus Pharmaceuticals | 2.66B |
| Travere Therapeutics | 2.57B |